Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the clinical effectiveness, cost-effectiveness and service users' views of enhanced early communication therapy by speech and language (SL) therapists compared with attention control (AC). DESIGN: Successful feasibility study followed by a randomised trial with economic evaluation, and nested qualitative study using 32 individual interviews. SETTING: Twelve English NHS hospital and community stroke services. PARTICIPANTS: One hundred and seventy adults with aphasia or dysarthria admitted to hospital with stroke, December 2006 to January 2010. Eligibility determined by NHS SL therapists. Seventeen people declined follow-up. INTERVENTIONS: A best-practice, flexible intervention by NHS SL therapists, up to three contacts per week for up to 16 weeks compared with a similar number of AC contacts by employed visitors. MAIN OUTCOME MEASURES: Primary outcome was blinded, functional communicative ability 6 months post randomisation on the Therapy Outcome Measure activity subscale (TOM). Secondary outcomes were participants' perceptions on the Communication Outcomes After Stroke scale (COAST); carers' perceptions of participants from part of the Carer COAST; carer well-being on Carers of Older People in Europe Index and quality-of-life items from Carer COAST. Serious adverse events (SAEs) were recorded. Economic evaluation: participants' utility (European Quality of Life-5 Dimensions), service use and cost data from medical records and carers, and a discrete choice experiment. RESULTS: Intervention typically started after 2 weeks, providing 22 contacts. Both groups improved on the TOM. The estimated 6 months' group difference [95% confidence interval (CI)] was 0.25 (-0.19 to 0.69) points in favour of SL therapy. Sensitivity analyses adjusting for baseline chance imbalance or not imputing values for decedents further reduced this difference. Per-protocol analyses rejected a possible dilution of therapy from controls refusing allocation and receiving NHS SL therapy. There was no evidence of added benefit of therapy on any secondary outcome measure or SAEs, although the latter were less frequent in the therapy group [odds ratio 0.42 (95% CI 0.16 to 1.1)]. Regardless of group allocation, interviewed participants reported positive impacts on their confidence and mood, identified drivers for change and valued early and sustained contact. Health economic analysis indicated a high level of uncertainty. Early enhanced SL therapy for communication is likely to be cost-effective only if decision-makers are prepared to pay ≥ £25,000 to gain one unit of utility. CONCLUSIONS: These findings exclude the possibility of a clinically significant difference of 0.5 points on the TOM. There was no evidence, on any measure, of added benefit of early communication therapy beyond that from AC. It is unclear whether therapy is more or less cost-effective than AC. Early, frequent contact was highly valued by users and had good uptake. Functional communication improved for both groups, plausibly due to natural recovery and early and regular opportunity to practise everyday communication with a professional (therapist/visitor). There is no evidence to recommend enhancing the provision of early communication therapy by a qualified SL therapist over and above usual care. SL therapy service reorganisation should consider skill mix and timing within a stepped care model and should take place within the context of a trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Scottish Intercollegiate Guidelines Network (SIGN)
Miller, J. (2002) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514020020010401 · Cited by 1,544
The National Institute for Clinical Excellence (NICE)
Rodgers, A.-T. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii92 · Cited by 966
National Institute for Clinical Excellence and its value judgments
Rawlins, M. D., & Culyer, A. J. (2004) · BMJ · doi:10.1136/bmj.329.7459.224 · Cited by 765
Using Discrete Choice Experiments to Value Health and Health Care
(2008) · The Economics of Non-Market Goods and Resources · doi:10.1007/978-1-4020-5753-3 · Cited by 765
Engelter, S. T., Gostynski, M., Papa, S., Frei, M., Born, C., Ajdacic-Gross, V., Gutzwiller, F., & Lyrer, P. A. (2006) · Stroke · doi:10.1161/01.str.0000221815.64093.8c · Cited by 688
Hoch, J. S., Briggs, A. H., & Willan, A. R. (2002) · Health Economics · doi:10.1002/hec.678 · Cited by 535
Enderby, P. M., Wood, V. A., Wade, D. T., & Hewer, R. L. (1986) · International Rehabilitation Medicine · doi:10.3109/03790798709166209 · Cited by 266
Psychological distress after stroke and aphasia: the first six months
Hilari, K., Northcott, S., Roy, P., Marshall, J., Wiggins, R. D., Chataway, J., & Ames, D. (2010) · Clinical Rehabilitation · doi:10.1177/0269215509346090 · Cited by 263
The efficacy of treatment for aphasic persons: a meta-analysis
Robey, R. R. (1994) · Brain and Language · doi:10.1006/brln.1994.1060 · Cited by 235
Upper limb recovery after stroke: The stroke survivors' perspective
Barker, R. N., & Brauer, S. G. (2005) · Disability and Rehabilitation · doi:10.1080/09638280500075717 · Cited by 214
Cited by
Speech and language therapy for aphasia following stroke
Brady, M. C., Kelly, H., Godwin, J., Enderby, P., & Campbell, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000425.pub4 · Cited by 1,159
Bowen, A., Hesketh, A., Patchick, E., Young, A., Davies, L., Vail, A., Long, A. F., Watkins, C., Wilkinson, M., Pearl, G., et al. (2012) · BMJ · doi:10.1136/bmj.e4407 · Cited by 229
Self-citationPalmer, R., Dimairo, M., Cooper, C., Enderby, P., Brady, M., Bowen, A., Latimer, N., Julious, S., Cross, E., Alshreef, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30192-9 · Cited by 200
Self-citationInterventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury
Mitchell, C., Bowen, A., Tyson, S., Butterfint, Z., & Conroy, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002088.pub3 · Cited by 111
Self-citationSickert, A., Anders, L.-C., Munte, T. F., & Sailer, M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304297 · Cited by 63
Metadata
- Authors
- Bowen, A., Hesketh, A., Patchick, E., Young, A., Davies, L., Vail, A., Long, A., Watkins, C., Wilkinson, M., Pearl, G., Lambon Ralph, M., & Tyrrell, P.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Leeds (GB)
- University of Lancashire (GB)
- Corresponding author
- Bowen, A
- Venue
- Health Technology Assessment
- Published
- 2012-05
- Volume
- 16
- Issue
- 26
- Pages
- 1-160
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2159668673
- Cited by
- 56
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 10 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 3
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health Technology Assessment programme (02/11/04)
- Topics
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Keywords
- aphasia, dysarthria, stroke, speech therapy, cost-effectiveness, service user perceptions, caregiver well-being, quality of life, communication outcomes, serious adverse events, discrete choice experiment, utility value, health economic evaluation
- MeSH terms
- Stroke Rehabilitation, Adult, Aged, Aged, 80 and over, Aphasia, Dysarthria, Feasibility Studies, Female, United Kingdom, Humans, Interviews as Topic, Male, Middle Aged, Speech Therapy, State Medicine, Patient Satisfaction, Outcome Assessment, Health Care, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study). https://app.cochat.ai/papers/10.3310/hta16260
- The paper
- Bowen, A., Hesketh, A., Patchick, E., Young, A., Davies, L., Vail, A., Long, A., Watkins, C., Wilkinson, M., Pearl, G., Lambon Ralph, M., & Tyrrell, P. (2012). Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study). Health Technology Assessment. https://doi.org/10.3310/hta16260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.